Part 3: Myelodysplastic syndromes—Treatment of low-risk patients without the 5q deletion

Velloso, E. D. R. P., Magalhães, S. M. M., Chauffaille, M. de L. L. F., Buzzini, R., & Bernardo, W. M. (2018). Part 3: Myelodysplastic syndromes—Treatment of low-risk patients without the 5q deletion. Hematology, Transfusion and Cell Therapy, 40(3), 267–273. https://doi.org/10.1016/j.htct.2018.05.011